Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 1
1990 4
1991 1
1992 1
1993 2
1995 2
1996 2
1997 1
2001 1
2005 2
2013 1
2019 3
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

22 results
Results by year
Filters applied: . Clear all
Page 1
Rifamycin SV exhibits strong anti-inflammatory in vitro activity through pregnane X receptor stimulation and NFκB inhibition.
Rosette C, Agan FJ, Rosette N, Moro L, Mazzetti A, Hassan C, Gerloni M. Rosette C, et al. Among authors: Rosette N. Drug Metab Pharmacokinet. 2019 Jun;34(3):172-180. doi: 10.1016/j.dmpk.2019.01.002. Epub 2019 Jan 17. Drug Metab Pharmacokinet. 2019. PMID: 31101589 Free article.
Anti-inflammatory and immunomodulatory activities of rifamycin SV.
Rosette C, Buendia-Laysa F Jr, Patkar S, Moro L, Celasco G, Bozzella R, Ajani M, Gerloni M. Rosette C, et al. Int J Antimicrob Agents. 2013 Aug;42(2):182-6. doi: 10.1016/j.ijantimicag.2013.04.020. Epub 2013 Jun 5. Int J Antimicrob Agents. 2013. PMID: 23756321
Immunoregulatory genes and immunosuppression by glucocorticoids.
Auphan N, Didonato JA, Helmberg A, Rosette C, Karin M. Auphan N, et al. Among authors: Rosette C. Arch Toxicol Suppl. 1997;19:87-95. doi: 10.1007/978-3-642-60682-3_8. Arch Toxicol Suppl. 1997. PMID: 9079197 No abstract available.
22 results
Jump to page
Feedback